Articles by John Towns

John Towns

Towns_John_K@lilly.com

John Towns is the senior director of global CMC regulatory affairs at Eli Lilly and Company. Towns is also the chair of the Quality by Design Working Group of the PhRMA Biologics and Biotechnology Leadership Committee

Quality by Design for Biotechnology Products—Part 1
November 1, 2009
By: Taruna Arora , Roger Greene , Jennifer Mercer , Paul Tsang , Meg Casais , Stuart Feldman , Jutta Look , Tony Lubiniecki , Joseph Mezzatesta , Stefanie Pluschkell , Mark Rosolowsky , Anurag S. Rathore, PhD , Mark Schenerman , Tim Schofield , Samantha Sheridan , Paul Smock , Sally Anliker , Lois Atkins , Bernerd McGarvey , Bruce Meiklejohn , Jim Precup , John Towns

First in a three-part series that discusses the complexities of QbD implementation in biotech product development.